The Journal of infectious diseases · 2026
Repeat Influenza Vaccination Effects in 2021/22 and 2022/23 in a Community-Based Cohort in Hong Kong.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zhong Jennifer C, Zhong Shuyi, Touyon Lisa, Ho Faith, Au Niki Y M, Cheng Samuel M S, Ip Dennis K M, Peiris Malik, Martin Emily T, Cobey Sarah, Wong Sook-San, Leung Nancy H L, Cowling Benjamin J
Аннотация
BACKGROUND: Repeated influenza vaccination has been associated with attenuated immune responses and reduced clinical effectiveness. Most studies have focused on the responses at 30 days post-vaccination. As influenza did not circulate in Hong Kong during the COVID-19 pandemic, we were able to investigate vaccine responses in the absence of infections.
METHODS: In this community-based cohort study in Hong Kong, we investigated the impact of repeated annual influenza vaccination on antibody titer boosting and waning rates of 8 contemporary vaccine strains in 2021/22 and 2022/23, using hemagglutination inhibition assays. We estimated the impact of repeat vaccination on mean fold rises and on post-vaccination titers. We investigated differences by vaccination history in titer waning rates using a power law model.
RESULTS: We found differences in post-vaccination geometric mean and mean fold rises in titers against several vaccine strains in repeat vaccinees in 2022/23 compared to 2021/22. However, although participants with higher vaccination uptake had significantly slower antibody waning against A/Victoria/2570/2019, B/Phuket/3073/2013, and B/Austria/1359417/2019, they reached similar antibody titers at 6 months post-vaccination.
CONCLUSIONS: Our findings suggest that repeated influenza vaccination is associated with reduced titer increase at day 14 post-vaccination, but has less impact on antibody levels at 6 months post-vaccination.
METHODS: In this community-based cohort study in Hong Kong, we investigated the impact of repeated annual influenza vaccination on antibody titer boosting and waning rates of 8 contemporary vaccine strains in 2021/22 and 2022/23, using hemagglutination inhibition assays. We estimated the impact of repeat vaccination on mean fold rises and on post-vaccination titers. We investigated differences by vaccination history in titer waning rates using a power law model.
RESULTS: We found differences in post-vaccination geometric mean and mean fold rises in titers against several vaccine strains in repeat vaccinees in 2022/23 compared to 2021/22. However, although participants with higher vaccination uptake had significantly slower antibody waning against A/Victoria/2570/2019, B/Phuket/3073/2013, and B/Austria/1359417/2019, they reached similar antibody titers at 6 months post-vaccination.
CONCLUSIONS: Our findings suggest that repeated influenza vaccination is associated with reduced titer increase at day 14 post-vaccination, but has less impact on antibody levels at 6 months post-vaccination.